# Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

> **NCT03150212** · NA · COMPLETED · sponsor: **Lesaffre International** · enrollment: 456 (actual)

## Conditions studied

- Constipation-predominant Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Saccharomyces cerevisiae CNCM I-3856
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03150212
- **Lead sponsor:** Lesaffre International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2019-05-09
- **Final completion:** 2019-05-09
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150212, "Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03150212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*